COVID-19, lab diagnostics and health policy in Asia Pacific: insights from Dr Swee Kheng Khor (RED 2021)

BulletArticle
共享以下内容:
COVID-19, lab diagnostics and health policy in Asia Pacific: insights from Dr Swee Kheng Khor (RED 2021)

The COVID-19 pandemic has demonstrated the enduring importance of diagnostics and brought clinical lab leaders in closer contact with health policymakers than ever before. This talk by Dr Swee Kheng Khor, a global health expert with deep experience in the Asia Pacific region, explores key considerations for the clinical lab community to make the most of this unique moment. This includes a high-level view of where clinical labs fit into healthcare systems; strategies for increasing investment in clinical lab services; and recommended policy areas for lab leaders to focus on in the post-COVID era.

Watch the full talk below (click the buttons on the play bar to jump to any specific segment that interests you).

共享以下内容:

有关同一主题的更多信息

推荐主题

SequencingRED 2020Rare Diseases
下次阅读
Scroll to Top